At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
ABVX Abivax S.A.
Market Closed 07-17 16:00:00 EDT
136.65
-1.12
-0.81%
盘后136.00
-0.65-0.48%
19:59 EDT
High138.36Low134.00Vol1.41M
Open136.07D1 Closing137.77Amplitude3.16%
Mkt Cap11.90BTradable Cap10.10BTotal Shares87.05M
T/O191.70MT/O Rate1.91%Tradable Shares73.91M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Abivax re-engages Centerview amid renewed takeover interest, La Lettre says
TIPRANKS  ·  02:10
Abivax re-engages Centerview amid renewed takeover interest, La Lettre says
Valerio Therapeutics, Abivax Enter R&D Collaboration for Inflammatory Disease Therapies
MT Newswires Live  ·  07-16 18:08
Valerio Therapeutics, Abivax Enter R&D Collaboration for Inflammatory Disease Therapies
Abivax price target raised to $175 from $165 at Piper Sandler
TIPRANKS  ·  07-09
Abivax price target raised to $175 from $165 at Piper Sandler
Abivax Closes $920 Million ADS Offering
MT Newswires Live  ·  07-07
Abivax Closes $920 Million ADS Offering
Abivax Rebounds, but Obefazimod Unlikely to Replace JAK Inhibitors, Wedbush Says
MT Newswires Live  ·  07-06
Abivax Rebounds, but Obefazimod Unlikely to Replace JAK Inhibitors, Wedbush Says
Abivax Sa : Wedbush Raises Target Price to $140 from $110
THOMSON REUTERS  ·  07-06
Abivax Sa : Wedbush Raises Target Price to $140 from $110
Wedbush Raises Price Target on Abivax to $140 From $110, Keeps Neutral Rating
MT Newswires Live  ·  07-06
Wedbush Raises Price Target on Abivax to $140 From $110, Keeps Neutral Rating
Movement Alert｜Abivax S.A. Rises 6.46% in Pre-Market Trading, $920 Million ADS Offering Officially Closes Boosting Bullish Sentiment
Market Focus  ·  07-06
Movement Alert｜Abivax S.A. Rises 6.46% in Pre-Market Trading, $920 Million ADS Offering Officially Closes Boosting Bullish Sentiment
Movement Alert｜Abivax S.A. Rises 5.74% Overnight, $920 Million ADS Offering Officially Closes as Underwriters Fully Exercise Over-Allotment Option
Market Focus  ·  07-06
Movement Alert｜Abivax S.A. Rises 5.74% Overnight, $920 Million ADS Offering Officially Closes as Underwriters Fully Exercise Over-Allotment Option
Movement Alert｜Abivax S.A. Rises 5.39% in Regular Trading, Underwriters Fully Exercise Overallotment Option Lifting Total Proceeds to $920 Million
Market Focus  ·  07-02
Movement Alert｜Abivax S.A. Rises 5.39% in Regular Trading, Underwriters Fully Exercise Overallotment Option Lifting Total Proceeds to $920 Million
Abivax Sa : Truist Securities Raises Target Price to $155 from $135
THOMSON REUTERS  ·  07-02
Abivax Sa : Truist Securities Raises Target Price to $155 from $135
Abivax price target raised to $155 from $135 at Truist
TIPRANKS  ·  07-02
Abivax price target raised to $155 from $135 at Truist
Abivax Says Underwriters Fully Exercise Option in ADS Offering
MT Newswires Live  ·  07-02
Abivax Says Underwriters Fully Exercise Option in ADS Offering
Analysts Offer Insights on Healthcare Companies: SCYNEXIS (SCYX) and Abivax SA Sponsored ADR (ABVX)
TIPRANKS  ·  07-02
Analysts Offer Insights on Healthcare Companies: SCYNEXIS (SCYX) and Abivax SA Sponsored ADR (ABVX)
Movement Alert｜Abivax S.A. Rises 6.27% in Pre-Market Trading, Market Rally Extends After Upsized $800 Million Offering Priced
Market Focus  ·  07-02
Movement Alert｜Abivax S.A. Rises 6.27% in Pre-Market Trading, Market Rally Extends After Upsized $800 Million Offering Priced
Movement Alert｜Abivax S.A. Rises 6.37% Overnight, Market Momentum Continues After Upsized $800 Million Equity Offering Priced
Market Focus  ·  07-02
Movement Alert｜Abivax S.A. Rises 6.37% Overnight, Market Momentum Continues After Upsized $800 Million Equity Offering Priced
Abivax Sa Shares up 5% After Co Nets $920 Mln in Gross Proceeds from Ads Offering
THOMSON REUTERS  ·  07-02
Abivax Sa Shares up 5% After Co Nets $920 Mln in Gross Proceeds from Ads Offering
Us-listed Shares of Abivax up 1.6% After Co Launches 6.4 Mln American Depositary Shares
THOMSON REUTERS  ·  07-01
Us-listed Shares of Abivax up 1.6% After Co Launches 6.4 Mln American Depositary Shares
Abivax Prices $800 Million Equity Offering
MT Newswires Live  ·  07-01
Abivax Prices $800 Million Equity Offering
U.S. Research Roundup- Dow, Palo Alto Networks, Zions Bancorporation
Reuters  ·  07-01
U.S. Research Roundup- Dow, Palo Alto Networks, Zions Bancorporation

Introduction

Company Name.
Abivax S.A.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis. ABIVAX Société Anonyme was incorporated in 2013 and is headquartered in Paris, France.
Issue price:
--